The life sciences era is here: The intersection of biotech and CRE

Innovative sectors such as cell and gene therapies, artificial intelligence and ancestry and genetic testing are all forecast to grow by as much as 37 percent annually in the next five years and drive a wave of demand for lab space, diagnostic centers and healthcare facilities, according to Cushman & Wakefield’s Life Sciences 2020: The Future report.

All of this research and growth require capital, not to mention talent. Together, National Institutes of Health (NIH), venture capital and corporate R&D invested an estimated $125 billion in the pharmaceuticals and life sciences sectors in 2018. In the current decade, growth in life science-related employment has been more than three times stronger than total U.S. employment. As capital has flowed into life sciences, employment has increased leading to greater demand for lab and office space and a 12-million-square-foot p